rfcnu has been researched along with Liver Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Jager, R; De Vassal, F; Gouveia, J; Imbach, JL; Jasmin, C; MacDonald, JS; Machover, D; Mathe, G; Misset, JL; Musset, M; Ribaud, P; Schein, P; Schwarzenberg, L; Serrou, B | 1 |
1 other study(ies) available for rfcnu and Liver Neoplasms
| Article | Year |
|---|---|
Study of nitrosourea glycosyl analogs--V. An oriented phase II trial of RFCNU.
Topics: Adult; Aged; Antineoplastic Agents; Digestive System Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukocyte Count; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Thrombocytopenia | 1982 |